Melissa A. Thompson

Melissa A. Thompson PhD is an accomplished professional in regulatory affairs, quality assurance, and clinical affairs, currently serving as a Global Regulatory specialist at Structure Therapeutics since August 2023. With extensive experience as a C-Suite Executive at Matrix Group since January 2017, Melissa has successfully strategized product development across pharmaceutical, medical device, and biotechnology sectors. Previous roles include Interim Vice President at Curis, Global Head of Regulatory Affairs at Visterra Inc., and founding positions at Hyndsight Vision Systems, which developed an innovative wireless collision avoidance system. As Vice President of Regulatory Affairs at Quotient Biodiagnostics, Melissa notably expanded the regulatory affairs department, and as Senior Director at Ventana/Roche Medical Systems, led global regulatory strategies for companion diagnostics. Melissa's expertise is further supported by a comprehensive educational background, including a PhD in Organizational Management from Concordia University and a master's degree from Temple University.